News Archives - Page 207 of 703

WednesdayNov 09, 2022 9:00 am

Flora Growth Corp. (NASDAQ: FLGC) Defines Path to Profitability and Portfolio Expansion with Proposed Franchise Global Health Inc. Acquisition

Flora Growth signed a definitive agreement with FGH to acquire 100% of all issued and outstanding shares by way of a statutory plan of agreement The deal is expected to close in December following the presentation of the agreement to shareholders; the acquisition will open Flora to the German and EU medical markets, increasing the company’s international revenue and providing essential distribution to German pharmacies and a growing wholesale market FGH’s acquisition adds to Flora’s expanding list of subsidiaries which currently comprise Vessel Brand Inc. and JustCBD, among others, and it is expected to deliver at least $3 million in…

TuesdayNov 08, 2022 11:15 am

REZYFi, Inc. Leverages Cannabis Industry Interests to Diversify Banking and Real Estate as DCC Prioritizes Research Project Funding

The California Department of Cannabis Control (“DCC”) has reserved $20 million in funding for research prioritizing cannabis projects, including potency, health impact, medicinal use, legacy cannabis genetics, and industry health The medicinal and recreational cannabis market size in the US is anticipated to reach $33 billion in 2022, with a revenue outlook of $52.6 billion by 2026 REZYFi Inc., through two wholly-owned subsidiaries, is positioned to be the first cannabis mortgage banker in the United States The state of California Department of Cannabis Control has reserved $20 million in funding for research that prioritizes numerous cannabis topics, including potency, health…

TuesdayNov 08, 2022 10:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Aiming to Address Unmet Patient Needs of Hypertensive Patients

Lexaria just completed its HYPER-H21-4 human clinical hypertension study, posting a sustained drop in blood pressure in normally active hypertensive patients With the success of this study, the company is working towards an IND application to seek FDA approval for its patented DehydraTECH(TM)-enabled CBD capsule formulation. 47% of adults live with hypertension but only 24% of them have it under control With its DehydraTECH-CBD, Lexaria hopes to not only address the severe unmet patient need associated with hypertension but also tap into a market that is set to be valued at $34 billion by 2030 Lexaria Bioscience (NASDAQ: LEXX), a…

TuesdayNov 08, 2022 9:45 am

Rising Investment In Clean Energy Drives Optimism for Correlate Infrastructure Partners Inc. (CIPI)

Nearly a decade has passed since the Paris Accords established international cooperation on curbing fossil fuel pollutants believed to be responsible for adversely affecting the earth’s climate, and some agencies worry that not enough is happening to meet the accords’ goals Despite concerns about obstacles to renewable energy adoption, the same agencies note that investment in climate-friendly technologies is rising Correlate Infrastructure Partners is a U.S.-based company works with the commercial real estate industry to drive the transition to climate-friendly energy sources, helping clients analyze their utilities use, identifying ways to improve their ESG outcomes, and presenting funding opportunities to…

TuesdayNov 08, 2022 9:00 am

Reklaim Ltd. (TSX.V: MYID) (OTCQB: MYIDF) Set to Benefit from Increased Government Focus on Online Privacy

The U.S. Federal Trade Commission is increasingly seeking to protect the online privacy rights of consumers The FTC recently sued data broker Kochava for brokering the geolocation details of millions of consumers Texas Attorney General Ken Paxton has filed suit against Google for allegedly collecting customer information without consent Reklaim enables users to reclaim their data – providing the option to delete it or monetize it A poll conducted during the summer of 2021 showed that 13 percent of UK teens and 6 percent of American teens linked Instagram usage to suicidal thoughts. Even more surprising is the fact that…

MondayNov 07, 2022 12:00 pm

GeoSolar Technologies Inc. Reimagining the Suburbs as Environmentally Green

2021 represented the first time in half a century that large urban counties experienced negative growth Migration to suburbs and exurban counties contribute more to carbon emissions, highlighting the need for a transition to renewable energy to combat climate change GeoSolar Technologies is an emerging leader with its whole-home system using solar, geothermal, and proprietary air filtration technologies Americans in 2021 exited urban counties in droves, heading for suburban and exurban counties at a record pace. From an environmental perspective, the transition can have unintended negative consequences, as people generally have more property outside the city, drive more, and use…

MondayNov 07, 2022 11:15 am

Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) Assisting EV Manufacturers in Reducing Costs; Company Announces Appointment of Samuel Yik as CFO

The manufacture of lower cost electric vehicles is conditional on the decrease of component costs, with battery packs forming one of the largest parts of their cost structure Hillcrest Energy Technologies’ revolutionary inverter technology, which forms an integral part of an electrical vehicle’s powertrain, allows EV’s to improve thermal management and reduce switching losses Improved power quality resulting from more efficient power inverters can enable automakers to obtain higher powertrain efficiency and consequently, reduce their battery packs Hillcrest Energy Technologies separately seized the opportunity to announce the appointment of Samuel Yik as their new CFO One of the world’s most…

MondayNov 07, 2022 10:30 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Is ‘One to Watch’

BiondVax has an exclusive worldwide license to commercialize NanoAbs for the treatment of COVID-19 The company plans to initiate a Phase 1/2a clinical trial of its inhaled COVID-19 therapeutic NanoAb in 2023 BiondVax has exclusive options for worldwide licenses for NanoAbs to treat other disorders with large, underserved needs The company has filed a Registration Statement with the SEC for an underwritten offering of shares BiondVax Pharmaceuticals (NASDAQ: BVXV) is a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses. In collaboration with the prestigious Max Planck Institute…

MondayNov 07, 2022 9:45 am

New Pharmaceutical Subsidiary Geared to Aid Odyssey Health, Inc. (ODYY) Development of Novel Solutions for Brain Related Medical Treatments

Odyssey Health Inc. is a medical product developer with a mission of filling unmet needs when it comes to acute emergencies involving patients’ central nervous systems The company recently announced the formation of a wholly owned subsidiary to help Odyssey develop its products as they move through the regulatory process Odyssey’s solutions include a breath-powered intranasal delivery mechanism and synthetic neurosteroids designed to provide rapid-response treatment for patients with concussions and a highly fatal pediatric neurological disease Odyssey Health also is developing solutions for heart disease detection, obstructed-airway choking and nerve agent exposure The concussion therapeutic solution recently completed Phase…

MondayNov 07, 2022 9:00 am

Flora Growth Corp. (NASDAQ: FLGC) Agreement to Acquire Multi-national Cannabis Operator Positions Company for New Strategic Growth in Europe

Flora Growth is a cannabis cultivator and international brand developer with a strong base of operations at its licensed facility in northern Colombia Flora recently announced its plans to acquire multi-national operator Franchise Global Health (“FGH”), the latest of its strategic acquisitions designed to boost revenues and expand Flora’s international footprint FGH is focused on the German market, where its subsidiary was the first company to sell cannabis Germany is in turn expected to provide the companies a launching pad for success in Europe, where opportunity is defined by the fact that currently Germany provides 75 to 80 percent of…

Site Search

Company Search

Category: News